Chloroform mode of action: Implications for cancer risk assessment

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 2, 1997, Pages 142-155

  Golden, Robert J ^a   Holm, Stewart E ^b   Robinson, Denise E ^c   Julkunen, Paivi H ^d   Reese, Elizabeth A ^e  

^a Environmental Risk Sciences   (United States)

^b Georgia Pacific Corporation   (United States)

^c International Life Sciences Institute   (United States)

^d The Coca Cola Company   (United States)

^e NATIONAL ACADEMY OF SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM;

ANIMAL CELL; ASPERGILLUS NIDULANS; CANCER RISK; CARCINOGENESIS; CATTLE; CELL DEATH; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ESCHERICHIA COLI; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CANCER; KIDNEY TUMOR; LUNG FIBROBLAST; LYMPHOCYTE; METHODOLOGY; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; THYMUS;

ANIMALIA; ASPERGILLUS; BOS TAURUS; EMERICELLA NIDULANS; ESCHERICHIA COLI; RODENTIA; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0030731832     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1161     Document Type: Article

References (96)

1. 1. Toxicologist. 36:1997;223.
2. J. V. Bruckner, 1993, Letter to the Agency for Toxic Substances and Disease Registry (ATSDR), Professor and Director of Toxicology, The University of Georgia, College of Pharmacy, Athens, Georgia.
3. 1. Environ. Health Perspect. 69:1986;49-58.
4. Butterworth B. E., Smith-Oliver T., Earle L., Lowry D., White R. D., Doolittle D., Working P., Cattley R. C., Jirtle R., Michalopoulos G., Strom S. Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 49:1989;1075-1084.
5. Butterworth B. E., Popp J. A., Conolly R. B., Goldsworthy T. L. Chemically induced cell proliferation in carcinogenesis. Vainio H., Magee P. N., McGregor D. B., McMichael A. J. Mechanisms of Carcinogenesis in Risk Identification. 1992;279-305 International Agency on Research Cancer, Lyon.
6. Butterworth B. E., Conolly R. B., Morgan K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 93:1995;129-146.
7. 1. Toxicologist. 36:1997;135.
8. Callen D. F., Wolf C. R., Philpot R. M. Cytochrome P-450 mediated genetic activity and cytotoxicity of seven halogenated aliphatic hydrocarbons inSaccharomyces cerevisiae. Environ. Health Crit. 163:1980.
9. Chiu N., Orme-Zavaleta J., Chiu A., Chen C., DeAngelo A., Brattin W., Blancaro J. Characterization of cancer risk associated with exposure to chloroform. J. Environ. Sci. Health. C14:1996;81-104.
10. Cohen S. M., Putilo D. T., Ellwein L. B. Pivotal role of increased cell proliferation in human carcinogenesis. Modern Pathol. 4:1991;371-382.
11. Cohen S. M., Ellwein L. B. Genetic errors, cell proliferation and carcinogenesis. Cancer Res. 51:1991;6493-6505.
12. Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science. 249:1990;1007-1011.
13. Condie L. W., Laurie R. D., Mills T., Robinson M., Beroz J. P. Effect of gavage vehicle on hepatotoxicity of carbon tetrachloride in CD-mice: Corn oil versus tween-60 aqueous emulsion. Fundam. Appl. Toxicol. 7:1986;199-206.
14. Corcoran G. B., Ray S. D. The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants. Toxicol. Appl. Pharmacol. 113:1992;167-183.
15. Corley R. A., Mendrala A. L., Smith F. A. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103:1990;512-527.
16. De Serres F. J., Ashby J. Evaluation of short-term tests for carcinogens. Progress in Mutation Research. 1981;Elsevier, New York.
17. DiRenzo A. B., Gandolfi A. J., Sipes I. G. Microsomal bioactivation and covalent binding of aliphatic halides to DNA. Toxicol. Lett. 11:1982;243-252.
18. Drinkwater N. R. Genetic control of hepatocarcinogenesis in C2H mice. Drug Metab. Rev. 26:1994;201-208.
19. Elia M. C., Storer R. D., Harmon L. S., Kraynak A. R., McKelvey T. W., Hertzog P. R., Keenan K. P., DeLuca J. G., Nichols W. W. Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay. Mutat. Res. 291:1993;193-205.
20. Elia M. C., Storer R. D., McKelvey T. W., Kraynak A. R., Barnum J. E., Harmon L. S., DeLuca J. G., Nichols W. W. Rapid DNA degradation in primary rat hepatocytes treated with divers cytotoxic chemicals: Analysis by pulsed field gel electrophoresis and implications for alkaline elution assays. Environ. Mol. Mutagen. 24:1994;181-191.
21. Eschenbrenner A. B., Miller E. Liver necrosis and the induction of carbon tetrachloride hepatomas in strain A mice. J. Natl. Cancer Inst. 6:1946;325-341.
22. Foran J. A. Principles for the selection of doses in chronic rodent bioassays. Environ. Health Perspec. 105:1997;18.
23. Gemma S., Faccioli S., Chieco P., Sbraccia M., Testai E., Vittozzi L. In vivo. Toxicol. Appl. Pharmacol. 141:1996;394-402.
24. Gocke E., King M-T., Eckhardt K., Wild D. Mutagenicity of cosmetics ingredients licensed by the European Communities. Environ. Health Crit. 163:1981.
25. 4Aspergillus nidulans. Environ. Health Crit. 163:1984.
26. Hart R. W., Keenan K., Turturro A., Abdo K. M., Leakey J., Lyn-Cook B. Symposium overview: Caloric restriction and toxicity. Fundam. Appl. Toxicol. 25:1995;184-195.
27. Haseman J. K., Rao G. N. Effect of corn oil, time-related changes and inter-laboratory variability on tumor occurrence in control Fischer 344 (F344/N) rats. Toxicol. Pathol. 20:1992;52-60.
28. Environmental Health Criteria. 163:1994.
29. Jagannath D. R., Vultaggio D. M., Brusick D. J. Genetic activity of 42 coded compounds in the mitotic gene conversion assay usingSaccharomyces cerevisiae. Environmental Health Criteria. 163:1981.
30. Jones H. B., Eldridge S. R., Butterworth B. E., Foster J. R. Measures of cell replication in risk/safety assessment of xenobiotic-induced, nongenotoxic carcinogenesis. Reg. Toxicol. Pharmacol. 23:1996;117-127.
31. Jorgenson T. A., Meirhenry E. F., Rushbrook C. J., Bull R. J., Robinson M. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5:1985;760-769.
32. Kassinova G. V., Kovaltsova S. V., Marfin S. V., Zakharov I. A. Activity of 40 coded compounds in differential inhibition and mitotic crossing-over assays in yeast. Environmental Health Criteria. 163:1981.
33. Kirkland D. J., Smith K. L., Van Abbe N. J. Failure of chloroform to induce chromosomal damage or sister-chromatid exchanges in cultured human lymphocytes and failure to induce reversion inEscherichia coli. Food Cosmet. Toxicol. 19:1981;651-656.
34. Land P. C., Owen E. L., Linde H. W. Morphologic changes in mouse spermatozoa after exposure to inhalational anesthetics during early spermatogenesis. Anesthesiology. 54:1981;53-56.
35. 1. Fundam. Appl. Toxicol. 20:1993;302-315.
36. 1. Fundam. Appl. Toxicol. 22:1994a;1-13.
37. 1. Fundam. Appl. Toxicol. 23:1994b;537-543.
38. 1. Environ. Mol. Mutagen. 23:1994c;132-136.
39. Larson J. L., Wolf D. C., Butterworth B. E. Induced cytolethality and regenerative cell proliferation in male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water for up to 3 weeks. Toxicology. 95:1994d;73-86.
40. Larson J. L., Wolf D. C., Morgan K. T., Butterworth B. E. The toxicity of one week exposures to inhaled chloroform in female B6C3F1 mice and male F-344 rats. Fundam. Appl. Toxicol. 22:1994e;431-446.
41. Larson J. L., Wolf D. C., Mery S., Morgan K. T., Butterworth B. E. Toxicity and cell proliferation in the liver, kidney and nasal passages of female F-344 rats, induced by chloroform administered by gavage. Food Chem. Toxicol. 33:1995a;443-456.
42. Larson J. L., Wolf D. C., Butterworth B. E. Induced regenerative cell proliferation in livers and kidneys of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology. 95:1995b;73-86.
43. 1. Fundam. Appl. Toxicol. 30:1996;118-137.
44. McClellan R. O. An annotated review of the NAS/NRC report: Science and judgment in risk assessment. Chem. Ind. Inst. Toxicol. (CIIT) Act. 14:1994;1-12.
45. Mehta R. D., von Borstel R. V. Mutagenic activity of 42 encoded compounds in the haploid yeast reversion assay, strain XV185-14C. Environ. Health Crit. 163. 1981.
46. 1. J. Appl. Toxicol. 9:1989;15-21.
47. Miralis J. C., Tyson C. K., Butterworth B. E. Detection of genotoxic carcinogens in thein vivo-in vitro. Environ. Mutagen. 4:1982;553-562.
48. A. D. Mitchell, B. C. Myhr, C. J. Rudd, 1988, Evaluation of the L5178Y mouse lymphoma cell system: Methods used and chemicals evaluated, Toxicological Profile for Chloroform, Agency for Toxic Substances and Disease Registry (ATSDR), U.S. Department of Health and Human Services, Public Health Service.
49. Moore L. Inhibition of lever-microsome calcium pump by in vivo administration of Ccl4, CHCl3, and 1,1-dichloroethylene (vinylidene chloride). Biochem. Pharmacol. 29:1980;2505-2511.
50. Morimoto K., Koizumi A. Trihalomethanes induce sister chromatid exchanges in human lymphocytes in vitro and mouse bone marrow cell in vivo. Environ. Res. 32:1983;72-79.
51. Nakajima T., Elovaara E., Okino T., Gelboib H., Klockars M., Riihimaki V., Aoyama T., Vainio H. Different contributions of cytochrome P4502E1 and P4502B1/2 to chloroform hepatotoxicity in rat. Toxicol. Appl. Pharmacol. 133:1995;215-222.
52. Carcinogenesis Bioassay of Chloroform. 1976;NCI, Bethesda.
53. Science and Judgment in Risk Assessment. 1994;National Academy Press, Washington.
54. Drinking Water and Health. 1987;National Academy Press, Washington.
55. Risk Assessment in the Federal Government: Managing the Process. 1983;National Academy Press, Washington.
56. 2+. Chem. Res. Toxicol. 3:1990;484-494.
57. Palmer A. K., Street A. E., Roe F. J. C., Worden A. N., Van Abbe N. J. Safety evaluation of toothpaste containing chloroform. II. Long-term study in rats. J. Environ. Pathol. Toxicol. 2:1979;821-833.
58. Pohl L. R., Martin J. L., George J. W. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 29:1980;3271-3276.
59. Pohl L. R., Booshan B., Whitaker N. F., Krishna G. Phosgene: a metabolite of chloroform. Biochem. Biophys. Res. Commun. 79:1977;684-691.
60. Preston-Martin S., Pike M. C., Ross R. K., Jones P. A., Henderson B. E. Increased cell division as a cause of human cancer. Cancer Res. 50:1990;7415-7421.
61. Reitz R. H., Mendrala A. L., Corley R. A., Quast J. F., Gargas M. L., Andersen M. E., Staats D. A., Conolly R. B. Estimating the risk of liver cancer associated with human exposures to chloroform. Toxicol. Appl. Pharmacol. 105:1990;443-459.
62. Reitz R. H., Fox R. H., Quast J. F. Mechanistic considerations for carcinogenic risk estimation: Chloroform. Environ. Health Perspect. 46:1982;163-168.
63. Roe F. J. C., Palmer A. K., Worden A. N. Safety evaluation of toothpaste containing chloroform. I. Long-term studies in mice. J. Environ. Pathol. Toxicol. 2:1979;799-819.
64. Rosenthal S. L. Review of the mutagenicity of chloroform. Environ. Mol. Mutagen. 10:1987;211-226.
65. Salamone M. F., Heddle J. A., Katz M. Mutagenic activity of 41 compounds in thein vivo. Environ. Health Crit. 163:1981.
66. San Agustin J. S., Lim-Sylianco C. Y. Mutagenic and clastogenic effects of chloroform. Environ. Health Crit. 163:1978.
67. Shelby M. D. Human germ cell mutations. Environ. Mol. Mutagen. 23:1995;30-34.
68. Sherr C. J. Cancer cell cycles. Science. 274:1996;1672-1677.
69. Simmon V. F., Kauhanen K., Tardiff R. G. Mutagenic activity of chemicals identified in drinking water. Scott D., Bridges B. A., Sobels F. H. Progress in Genetic Toxicology. 1977;249-258 Elsevier, New York.
70. Sipes I. G., Krishna G., Gillette J. R. Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: role of cytochrome P-450. Life Sci. 20:1977;1541-1548.
71. Stone R. News & Comment: A molecular approach to cancer risk. Science. 268:1995;356-357.
72. Sturrock J. Lack of mutagenic effect of halothane or chloroform on cultured cells using the azaguanine test system. Br. J. Anaesthesiol. 49:1977;207-210.
73. M. V. Templin, K. C. Jamison, B. C. Wolf, K. T. Morgan, B. E. Butterworth, 1995a, Chloroform-induced toxicity and cancer in male Osborne-Mendel and F-344 rats, Proceedings of a Workshop on Disinfectant By-Products in Drinking Water: Critical Issues in Health Effects Research, ILSI and U.S. Environmental Protection Agency, Chapel Hill, NC.
74. Templin M. V., Larson J. L., Butterworth B. E., Jamison K. C., Wong B. A., Wolf D. C. A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam. Appl. Toxicol. 32:1996a;109-125.
75. Templin M. V., Jamison K. C., Wolf B. C., Morgan K. T., Butterworth B. E. Comparison of chloroform-induced toxicity in the kidneys, liver and nasal passages of male Osborne-Mendel and F-344 rats. Cancer Lett. 104:1996b;71-78.
76. 1. Cancer Lett. 108:1996c;225-231.
77. 1. Toxicologist. 1996.
78. 1. Environ. Mol. Mutagen. 1997a.
79. 1. Proc. Am. Assoc. Cancer Res. 1997b.
80. 1.
81. Testai E., Gemma S., Vittozzi L. Bioactivation of chloroform in hepatic microsomes from rodent strains susceptible or resistant to CHC13 carcinogenicity. Toxicol. Appl. Pharmacol. 114:1992;197-203.
82. Testai E., Di Marzio S., Vittozzi L. Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol. Appl. Pharmacol. 104:1990;496-503.
83. Testai E., Vittozzi L. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform in mouse liver microsomes. Mech. Models Toxicol. 11:1986;42-44.
84. Topham J. C. Do induced sperm-head abnormalities in mice specifically identify mammalian mutagens rather than carcinogens? Environ. Health Crit. 163:1980.
85. Topham J. C. Evaluation of some chemicals by the sperm morphology assay. Environ. Health Crit. 163:1981.
86. Tsuchimoto T., Matter B. E. Activity of coded compounds in the micronucleus test. Environ. Health Crit. 163:1981.
87. Tumasonis C. F., McMartin D. N., Bush B. Toxicity of chloroform and bromodichloromethane when administered over a lifetime in rats. JEPTO. 7:1987;55-64.
88. Uehleke H., Werner T., Greim H., Kramer M. Metabolic activation of haloethanes and tests in vitro for mutagenicity. Environ. Health Crit. 163:1977.
89. U.S. Environmental Protection Agency (EPA), 1996, Proposed and Interim Guidelines for Carcinogen Risk Assessment, Office of Research and Development, Washington, DC.
90. U.S. Environmental Protection Agency (EPA), 1986, Guidelines for Carcinogen Risk Assessment, Washington, DC.
91. U.S. Environmental Protection Agency (EPA), 1985, Health Assessment Document for Chloroform: Final Report, Washington, DC.
92. Van Abbe N. J., Green T. J., Richold M., Roe F. J. C. Bacterial mutagenicity studies on chloroform in vitro. Food Chem. Toxicol. 20:1982;557-561.
93. Varma M. M., Ampy F. R., Vermak K. In vitro mutagenicity of water contaminant in complex mixtures. J. Appl. Toxicol. 8:1988;243-248.
94. White A. E., Takehisa S., Eger E. I., Wolff S., Stevens W. C. Sister-chromatid exchange induced by inhaled anesthetics. Anesthesiology. 50:1979;426-430.
95. 1, Proceedings of the Fifty-third Annual Meeting of the Japanese Cancer Association.
96. Yoshikawa K. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: Nongenotoxic carcinogens and genotoxic noncarcinogens. Environ. Health Perspect. 104:1996;40-46.